Comparative efficacy of TACI-Ig with TNF-alpha inhibitor and methotrexate in DBA/1 mice with collagen-induced arthritis

Lingling Zhang, Peipei Li, Shanshan Song, Yunjie Liu, Qingtong Wang, Yan Chang, Yujing Wu, Jingyu Chen, Wendi Zhao, Yunfang Zhang, Aiwu Zhou, Wei Wei

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

The efficacies of TACI-Ig, rhTNFR:Fc and Methotrexate were compared in collagen-induced arthritis (CIA) mice. Sixty animals were divided into six groups: TACI-Ig (9 mg/kg), rhTNFR:Fc (4 mg/kg), Methotrexate (2 mg/kg) and IgG-Fc (9 mg/kg) groups and were given medication for six weeks. Meanwhile, normal and CIA mice were given as control. The different efficacies of drugs were evaluated by the analyses of ankle joints and spleens pathology, cytokines, T and B lymphocytes subsets. TACI-Ig and rhTNFR:Fc reduced arthritis scores seven days later than that of Methotrexate. TACI-Ig and Methotrexate were superior to rhTNFR:Fc in reduction synovial hyperplasia and cell infiltration scores. The same result was observed for scores of spleens histopathology. TACI-Ig and Methotrexate presented higher efficacy than rhTNFR:Fc on B lymphocyte stimulator, but TACI-Ig was inferior to rhTNFR:Fc on TNF-alpha. TACI-Ig and Methotrexate could reduce significantly IgA and IgM, but rhTNFR:Fc had no effects on these immunoglobulins. TACI-Ig had more efficacy than rhTNFR:Fc in the decrease of CD4+CD154+ T cell. TACI-Ig and Methotrexate also reduced CD4+CD69+ T cell, rhTNFR:Fc had no effects on the T cell subset. TACI-Ig and Methotrexate were superior to rhTNFR:Fc on CD4+CD62L+T cells. TACI-Ig and Methotrexate could reduce CD19+IgD+ and CD19+CD21 + B cells, but rhTNFR:Fc had no obvious effect on above B cells subsets. TACI-Ig is as effective as rhTNFR:Fc and Methotrexate on CIA mice by ameliorating joint and spleen pathology, regulating T and B lymphocytes function, although different mechanisms among them. This study would be useful for treatment selection of rheumatoid arthritis in different pathological conditions.

Original languageEnglish (US)
Pages (from-to)113-123
Number of pages11
JournalEuropean Journal of Pharmacology
Volume708
Issue number1-3
DOIs
StatePublished - May 15 2013
Externally publishedYes

Fingerprint

Inbred DBA Mouse
Experimental Arthritis
Methotrexate
Tumor Necrosis Factor-alpha
B-Lymphocyte Subsets
T-Lymphocytes
Spleen
T-Lymphocyte Subsets
TACI receptor-IgG Fc fragment fusion protein
B-Lymphocytes
B-Cell Activating Factor
Pathology
Immunoglobulin D
Ankle Joint
Immunoglobulin A
Arthritis
Hyperplasia
Immunoglobulin M
Immunoglobulins
Rheumatoid Arthritis

Keywords

  • B lymphocyte stimulator
  • Collagen-induced arthritis
  • Lymphocyte
  • Methotrexate
  • RhTNFR:Fc
  • TACI-Ig

ASJC Scopus subject areas

  • Pharmacology

Cite this

Comparative efficacy of TACI-Ig with TNF-alpha inhibitor and methotrexate in DBA/1 mice with collagen-induced arthritis. / Zhang, Lingling; Li, Peipei; Song, Shanshan; Liu, Yunjie; Wang, Qingtong; Chang, Yan; Wu, Yujing; Chen, Jingyu; Zhao, Wendi; Zhang, Yunfang; Zhou, Aiwu; Wei, Wei.

In: European Journal of Pharmacology, Vol. 708, No. 1-3, 15.05.2013, p. 113-123.

Research output: Contribution to journalArticle

Zhang, L, Li, P, Song, S, Liu, Y, Wang, Q, Chang, Y, Wu, Y, Chen, J, Zhao, W, Zhang, Y, Zhou, A & Wei, W 2013, 'Comparative efficacy of TACI-Ig with TNF-alpha inhibitor and methotrexate in DBA/1 mice with collagen-induced arthritis', European Journal of Pharmacology, vol. 708, no. 1-3, pp. 113-123. https://doi.org/10.1016/j.ejphar.2013.02.025
Zhang, Lingling ; Li, Peipei ; Song, Shanshan ; Liu, Yunjie ; Wang, Qingtong ; Chang, Yan ; Wu, Yujing ; Chen, Jingyu ; Zhao, Wendi ; Zhang, Yunfang ; Zhou, Aiwu ; Wei, Wei. / Comparative efficacy of TACI-Ig with TNF-alpha inhibitor and methotrexate in DBA/1 mice with collagen-induced arthritis. In: European Journal of Pharmacology. 2013 ; Vol. 708, No. 1-3. pp. 113-123.
@article{5ffd97702b1a43dd8a3ead8ef3cc6449,
title = "Comparative efficacy of TACI-Ig with TNF-alpha inhibitor and methotrexate in DBA/1 mice with collagen-induced arthritis",
abstract = "The efficacies of TACI-Ig, rhTNFR:Fc and Methotrexate were compared in collagen-induced arthritis (CIA) mice. Sixty animals were divided into six groups: TACI-Ig (9 mg/kg), rhTNFR:Fc (4 mg/kg), Methotrexate (2 mg/kg) and IgG-Fc (9 mg/kg) groups and were given medication for six weeks. Meanwhile, normal and CIA mice were given as control. The different efficacies of drugs were evaluated by the analyses of ankle joints and spleens pathology, cytokines, T and B lymphocytes subsets. TACI-Ig and rhTNFR:Fc reduced arthritis scores seven days later than that of Methotrexate. TACI-Ig and Methotrexate were superior to rhTNFR:Fc in reduction synovial hyperplasia and cell infiltration scores. The same result was observed for scores of spleens histopathology. TACI-Ig and Methotrexate presented higher efficacy than rhTNFR:Fc on B lymphocyte stimulator, but TACI-Ig was inferior to rhTNFR:Fc on TNF-alpha. TACI-Ig and Methotrexate could reduce significantly IgA and IgM, but rhTNFR:Fc had no effects on these immunoglobulins. TACI-Ig had more efficacy than rhTNFR:Fc in the decrease of CD4+CD154+ T cell. TACI-Ig and Methotrexate also reduced CD4+CD69+ T cell, rhTNFR:Fc had no effects on the T cell subset. TACI-Ig and Methotrexate were superior to rhTNFR:Fc on CD4+CD62L+T cells. TACI-Ig and Methotrexate could reduce CD19+IgD+ and CD19+CD21 + B cells, but rhTNFR:Fc had no obvious effect on above B cells subsets. TACI-Ig is as effective as rhTNFR:Fc and Methotrexate on CIA mice by ameliorating joint and spleen pathology, regulating T and B lymphocytes function, although different mechanisms among them. This study would be useful for treatment selection of rheumatoid arthritis in different pathological conditions.",
keywords = "B lymphocyte stimulator, Collagen-induced arthritis, Lymphocyte, Methotrexate, RhTNFR:Fc, TACI-Ig",
author = "Lingling Zhang and Peipei Li and Shanshan Song and Yunjie Liu and Qingtong Wang and Yan Chang and Yujing Wu and Jingyu Chen and Wendi Zhao and Yunfang Zhang and Aiwu Zhou and Wei Wei",
year = "2013",
month = "5",
day = "15",
doi = "10.1016/j.ejphar.2013.02.025",
language = "English (US)",
volume = "708",
pages = "113--123",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "1-3",

}

TY - JOUR

T1 - Comparative efficacy of TACI-Ig with TNF-alpha inhibitor and methotrexate in DBA/1 mice with collagen-induced arthritis

AU - Zhang, Lingling

AU - Li, Peipei

AU - Song, Shanshan

AU - Liu, Yunjie

AU - Wang, Qingtong

AU - Chang, Yan

AU - Wu, Yujing

AU - Chen, Jingyu

AU - Zhao, Wendi

AU - Zhang, Yunfang

AU - Zhou, Aiwu

AU - Wei, Wei

PY - 2013/5/15

Y1 - 2013/5/15

N2 - The efficacies of TACI-Ig, rhTNFR:Fc and Methotrexate were compared in collagen-induced arthritis (CIA) mice. Sixty animals were divided into six groups: TACI-Ig (9 mg/kg), rhTNFR:Fc (4 mg/kg), Methotrexate (2 mg/kg) and IgG-Fc (9 mg/kg) groups and were given medication for six weeks. Meanwhile, normal and CIA mice were given as control. The different efficacies of drugs were evaluated by the analyses of ankle joints and spleens pathology, cytokines, T and B lymphocytes subsets. TACI-Ig and rhTNFR:Fc reduced arthritis scores seven days later than that of Methotrexate. TACI-Ig and Methotrexate were superior to rhTNFR:Fc in reduction synovial hyperplasia and cell infiltration scores. The same result was observed for scores of spleens histopathology. TACI-Ig and Methotrexate presented higher efficacy than rhTNFR:Fc on B lymphocyte stimulator, but TACI-Ig was inferior to rhTNFR:Fc on TNF-alpha. TACI-Ig and Methotrexate could reduce significantly IgA and IgM, but rhTNFR:Fc had no effects on these immunoglobulins. TACI-Ig had more efficacy than rhTNFR:Fc in the decrease of CD4+CD154+ T cell. TACI-Ig and Methotrexate also reduced CD4+CD69+ T cell, rhTNFR:Fc had no effects on the T cell subset. TACI-Ig and Methotrexate were superior to rhTNFR:Fc on CD4+CD62L+T cells. TACI-Ig and Methotrexate could reduce CD19+IgD+ and CD19+CD21 + B cells, but rhTNFR:Fc had no obvious effect on above B cells subsets. TACI-Ig is as effective as rhTNFR:Fc and Methotrexate on CIA mice by ameliorating joint and spleen pathology, regulating T and B lymphocytes function, although different mechanisms among them. This study would be useful for treatment selection of rheumatoid arthritis in different pathological conditions.

AB - The efficacies of TACI-Ig, rhTNFR:Fc and Methotrexate were compared in collagen-induced arthritis (CIA) mice. Sixty animals were divided into six groups: TACI-Ig (9 mg/kg), rhTNFR:Fc (4 mg/kg), Methotrexate (2 mg/kg) and IgG-Fc (9 mg/kg) groups and were given medication for six weeks. Meanwhile, normal and CIA mice were given as control. The different efficacies of drugs were evaluated by the analyses of ankle joints and spleens pathology, cytokines, T and B lymphocytes subsets. TACI-Ig and rhTNFR:Fc reduced arthritis scores seven days later than that of Methotrexate. TACI-Ig and Methotrexate were superior to rhTNFR:Fc in reduction synovial hyperplasia and cell infiltration scores. The same result was observed for scores of spleens histopathology. TACI-Ig and Methotrexate presented higher efficacy than rhTNFR:Fc on B lymphocyte stimulator, but TACI-Ig was inferior to rhTNFR:Fc on TNF-alpha. TACI-Ig and Methotrexate could reduce significantly IgA and IgM, but rhTNFR:Fc had no effects on these immunoglobulins. TACI-Ig had more efficacy than rhTNFR:Fc in the decrease of CD4+CD154+ T cell. TACI-Ig and Methotrexate also reduced CD4+CD69+ T cell, rhTNFR:Fc had no effects on the T cell subset. TACI-Ig and Methotrexate were superior to rhTNFR:Fc on CD4+CD62L+T cells. TACI-Ig and Methotrexate could reduce CD19+IgD+ and CD19+CD21 + B cells, but rhTNFR:Fc had no obvious effect on above B cells subsets. TACI-Ig is as effective as rhTNFR:Fc and Methotrexate on CIA mice by ameliorating joint and spleen pathology, regulating T and B lymphocytes function, although different mechanisms among them. This study would be useful for treatment selection of rheumatoid arthritis in different pathological conditions.

KW - B lymphocyte stimulator

KW - Collagen-induced arthritis

KW - Lymphocyte

KW - Methotrexate

KW - RhTNFR:Fc

KW - TACI-Ig

UR - http://www.scopus.com/inward/record.url?scp=84877044820&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84877044820&partnerID=8YFLogxK

U2 - 10.1016/j.ejphar.2013.02.025

DO - 10.1016/j.ejphar.2013.02.025

M3 - Article

VL - 708

SP - 113

EP - 123

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 1-3

ER -